Zinc Supplementation Prior to Botox Injections for Spasmodic Dysphonia
NCT05892770 · Status: ACTIVE_NOT_RECRUITING · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 36
Last updated 2025-02-25
Summary
One initial study has shown that Botulinum Toxin (BT) in combination with zinc supplementation may increase the duration of effects BT treatment. This initial study was in the context of facial aesthetics. The purpose of the present study is to determine the effect, if any, of oral zinc supplementation prior to BT in the treatment of spasmodic dysphonia. If positive effects will be observed, this would help reduce the burden of disease for these patients.
Conditions
- Spasmodic Dysphonia
Interventions
- DRUG
-
Zinc gluconate supplement
Subjects will take a 50 mg zinc gluconate supplement at breakfast for the five days leading up to their next injection appointment. They will also answer questionnaires and provide audio recordings at various time points of the two injection cycles, which is roughly six months.
- DRUG
-
Botulinum toxin type A
This is the current standard of care for treatment of spasmodic dysphonia. Botox injection goes into the vocal cord muscle, and will be occur in both the control and experimental arms of the study.
Sponsors & Collaborators
-
University of Florida
lead OTHER
Principal Investigators
-
Neil Chheda · University of Florida
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 99 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-08-01
- Primary Completion
- 2025-12-31
- Completion
- 2025-12-31
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Evaluation the Efficacy of Zinc on Botulinum Toxin A Injection
NCT07270042 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Zinc as an Adjunctive Therapy for Cervical Dystonia
NCT07140874 ·Status: RECRUITING ·Phase: PHASE2
-
Botulinum Toxin A in Patients With Myofascial Pain Syndrome With and Without Zinc Supplementation
NCT05605886 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
The Effect of Vocal Rest Versus Vocalization Following Xeomin® Injections in Spasmodic Dysphonia
NCT03129087 ·Status: UNKNOWN ·Phase: NA
-
Reversal of Botulinum Neurotoxin Injection Related Dysphonia With Pyridostigmine
NCT05110417 ·Status: UNKNOWN ·Phase: PHASE4
-
Onabotulinum Toxin A (Botox) in the Treatment of Transfer Dysphagia
NCT04695600 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Spasmodic Dysphonia Interviews
NCT06561334 ·Status: ACTIVE_NOT_RECRUITING
-
Dysphonia Pain Perception Following Botulinum Toxin Injections
NCT06767215 ·Status: COMPLETED ·Phase: NA
-
Study of Abobotulinum Toxin Versus Neubotulinum Toxin Injection For Hemifacial Spasm in Thai Patients
NCT04589364 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Patient Satisfaction With Treatment of BOTOX® Cosmetic for the Temporary Correction of Moderate to Severe Glabellar Lines
NCT00856414 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Botulinum Toxin Type A on Swallowing in Patients With Cervical Dystonia
NCT01384214 ·Status: COMPLETED ·Phase: PHASE4
-
BOTOX® (onabotulinumtoxinA) Treatment of Masseter Muscle Prominence
NCT03861936 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of Efficacy and Safety of Two Different Types of Botulinum Toxin Type A in Moderate to Severe Cervical Dystonia
NCT00528541 ·Status: COMPLETED ·Phase: PHASE4
-
Botulinum Toxin Injection in the UES for R-CPD
NCT06356025 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Firdapse for Post-BOTOX Vocal Weakness
NCT05123053 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate Safety, Efficacy of Botulinum Toxin Type A in Patients With Cervical Dystonia
NCT00564681 ·Status: COMPLETED ·Phase: PHASE2
-
Botulinum Toxin A in the Treatment of Hemifacial Spasm
NCT03306940 ·Status: UNKNOWN ·Phase: NA
-
DaxibotulinumtoxinA Injection for Treatment of Adductor Spasmodic Dysphonia
NCT05158166 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Efficacy and Safety of 10-Week or Shorter vs 12-Week or Longer Injection Intervals of Botulinum Toxin
NCT05103202 ·Status: COMPLETED
-
The Effect of Botulinum Toxin A on Headache Attributed to TMD
NCT03346252 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Treatment of Temporo-Myofascial Disorder of Muscular Origin Using Botulinum Toxin: A Prospective Study
NCT02810015 ·Status: UNKNOWN ·Phase: PHASE2
-
A Retrospective Chart Review of BOTOX® and Xeomin® for the Management of Cervical Dystonia and Blepharospasm
NCT02245958 ·Status: COMPLETED
-
A Phase 2 Trial of Deep Brain Stimulation for Spasmodic Dysphonia
NCT04938154 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Trial Evaluating Xeomin® (incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
NCT01287247 ·Status: COMPLETED
-
Assessment of Effectiveness and Safety of Dysport® for the Treatment of Hemifacial Spasm
NCT00276315 ·Status: COMPLETED ·Phase: PHASE3